Thyroid function alterations after radiofrequency ablation in benign thyroid nodule management
Therapeutic Advances in Endocrinology and Metabolism · 2026-03 · 17
DOI: 10.1177/20420188261432727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Endocrinology and Metabolism, online erschienen am 23.03.2026. Verfasst von Yi-Han Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Radiofrequency ablation (RFA) has gained recognition as a highly effective treatment for benign thyroid nodules (BTNs). However, post-procedural thyroid function changes have been reported.
Objectives
This study specifically focuses on the potential link between changes in thyroid function and the volume reduction ratio (VRR) of treated nodules. Additionally, it seeks to evaluate whether fluctuations in thyroid function at mid-term follow-up can serve as early indicators for the development of long-term hypothyroidism following RFA.
Design
Retrospective cohort study.
Methods
In this study, 50 euthyroid individuals (mean age = 47.1 years; 43 females, 7 males) with a total of 72 BTNs (median volume = 4.61 mL) undergoing RFA were evaluated. Comprehensive assessments, including clinical examinations, ultrasound imaging, and blood tests, were conducted at specific intervals (pre-RFA, and at 6 months, 12 months, and annually post-RFA).
Results
The mean follow-up period was 22.3 months. Both medium-term and long-term follow-ups revealed significant reductions in triiodothyronine (T3) levels ( p = 0.010, p = 0.036) and elevations in thyroid-stimulating hormone (TSH) levels ( p < 0.001, p = 0.006) compared to baseline measurements. A negative correlation was found between medium-term T3 levels and long-term VRR ( r = −0.475, p = 0.001). Furthermore, patients with lower T3 levels during medium-term follow-up demonstrated a significantly higher long-term VRR compared to those with higher T3 levels (0.89 vs 0.77, p = 0.030).
Conclusion
Following RFA, notable alterations in thyroid function were observed, without meeting the criteria of hypothyroidism. Additionally, a lower mid-term T3 level may be indicative of a better VRR during long-term follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
- Department of Radiology, Pingtung Christian Hospital, Pingtung, Taiwan.
- Department of Diagnostic Radiology, Kaohsiung Municipal Fong Shan Hospital-Under the Management of Chang Gung Medical Foundation, Kaohsiung, Taiwan.
- Department of Diagnostic Radiology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.
- Department of Radiology, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan.
- Thyroid Head and Neck Ablation Center, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Yi-Han Chen, Pi-Ling Chiang, Cheng-Kang Wang, An-Ni Lin, Wei-Che Lin
Zitieren
APA
Chen, Y. H., Chiang, P. L., Wang, C. K., Lin, A. N., Chang, Y. H., Chou, C. K., & Lin, W. C. (2026). Thyroid function alterations after radiofrequency ablation in benign thyroid nodule management. Therapeutic Advances in Endocrinology and Metabolism, 17. https://doi.org/10.1177/20420188261432727
Vancouver
Chen YH, Chiang PL, Wang CK, Lin AN, Chang YH, Chou CK, et al. Thyroid function alterations after radiofrequency ablation in benign thyroid nodule management. Therapeutic Advances in Endocrinology and Metabolism. 2026;17. doi:10.1177/20420188261432727
BibTeX
@article{Chen2026,
author = {Chen, Yi-Han and Chiang, Pi-Ling and Wang, Cheng-Kang and Lin, An-Ni and Chang, Yen-Hsiang and Chou, Chen-Kai and Lin, Wei-Che},
title = {Thyroid function alterations after radiofrequency ablation in benign thyroid nodule management},
journal = {Therapeutic Advances in Endocrinology and Metabolism},
year = {2026},
volume = {17},
doi = {10.1177/20420188261432727}
}
EUVIMED